Rice Hall James & Associates LLC purchased a new stake in Doximity, Inc. (NASDAQ:DOCS – Get Rating) during the third quarter, Holdings Channel reports. The institutional investor purchased 204,911 shares of the company's stock, valued at approximately $6,192,000.

A number of other institutional investors have also recently added to or reduced their stakes in DOCS. Bank of New York Mellon Corp grew its stake in Doximity by 60.6% in the 1st quarter. Bank of New York Mellon Corp now owns 172,855 shares of the company's stock valued at $9,004,000 after acquiring an additional 65,196 shares during the period. US Bancorp DE grew its stake in Doximity by 325.4% in the 1st quarter. US Bancorp DE now owns 2,646 shares of the company's stock valued at $138,000 after acquiring an additional 2,024 shares during the period. Cambridge Investment Research Advisors Inc. grew its stake in Doximity by 417.4% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 21,099 shares of the company's stock valued at $1,099,000 after acquiring an additional 17,021 shares during the period. Natixis Advisors L.P. acquired a new stake in Doximity in the 1st quarter valued at $983,000. Finally, BlackRock Inc. grew its stake in Doximity by 53.6% in the 1st quarter. BlackRock Inc. now owns 2,052,183 shares of the company's stock valued at $106,898,000 after acquiring an additional 716,547 shares during the period. Institutional investors and hedge funds own 52.48% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on DOCS shares. BTIG Research started coverage on shares of Doximity in a research note on Thursday, October 13th. They set a "neutral" rating on the stock. Morgan Stanley cut shares of Doximity from an "equal weight" rating to an "underweight" rating and lowered their target price for the stock from $32.00 to $29.00 in a research note on Friday, January 6th. Evercore ISI lifted their target price on shares of Doximity from $28.00 to $32.00 in a research note on Friday, November 11th. Wells Fargo & Company lifted their target price on shares of Doximity from $38.00 to $44.00 and gave the stock an "overweight" rating in a research note on Friday, November 11th. Finally, Piper Sandler lowered their target price on shares of Doximity from $39.00 to $35.00 in a research note on Friday, November 11th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $41.40.

Doximity Trading Down 0.4 %

Doximity (NASDAQ:DOCS – Get Rating) last issued its quarterly earnings data on Thursday, November 10th. The company reported $0.12 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.12. The firm had revenue of $102.19 million for the quarter, compared to analyst estimates of $99.86 million. Doximity had a net margin of 36.70% and a return on equity of 16.41%. Equities research analysts forecast that Doximity, Inc. will post 0.52 earnings per share for the current year.

Doximity Profile

(Get Rating)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

• Get a free copy of the StockNews.com research report on Doximity (DOCS)
• MarketBeat: Week in Review 01/09-01/13
• JPMorgan Chase Falls As Banks Brace For Recession
• Why is the Bed Bath & Beyond Stock Price up 261%?
• Roku Stock Price is Trending, Here's Why
• Carvana Stock Rally, Here's What You Need to Know

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Get Rating).

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.